| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2011 | WO2011082422A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications |
| 07/07/2011 | WO2011082381A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/07/2011 | WO2011082369A2 Injectable formulations for parenteral administration |
| 07/07/2011 | WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/07/2011 | WO2011082189A1 Production of hemagglutinin-neuraminidase protein in microalgae |
| 07/07/2011 | WO2011082087A2 Dps fusion proteins for use in vaccines and diagnostics |
| 07/07/2011 | WO2011081904A1 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 07/07/2011 | WO2011081765A1 Pythium immunotherapy |
| 07/07/2011 | WO2011081598A1 New antigens for use in a vaccine against h.pylori infection |
| 07/07/2011 | WO2011081294A2 Recombinant adenovirus having anti-angiogenesis activity |
| 07/07/2011 | WO2011081189A1 Anti-iga1 antibody |
| 07/07/2011 | WO2011081164A1 Anti-cd27 antibody |
| 07/07/2011 | WO2011080796A1 Anti-cdh3 antibodies and uses thereof |
| 07/07/2011 | WO2011080765A2 Recombinant human bivalent diabody against rabies virus and uses thereof |
| 07/07/2011 | WO2011080595A2 Polysaccharide immunogens conjugated to e. coli carrier proteins |
| 07/07/2011 | WO2011080401A1 Receptor tyrosine kinase-binding compositions |
| 07/07/2011 | WO2011080396A2 Use of blood group status ii |
| 07/07/2011 | WO2011080395A2 Use of blood group status i |
| 07/07/2011 | WO2011080342A1 Administration route for a composition to protect an animal against rhodococcus equi |
| 07/07/2011 | WO2011080322A1 Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia |
| 07/07/2011 | WO2011080314A2 Novel modulators of trail signalling |
| 07/07/2011 | WO2011080271A2 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof |
| 07/07/2011 | WO2011080126A1 Agonists of tlr4 and 9 receptors for preventing septic complications of post-traumatic immune depression in patients hospitalized for severe trauma |
| 07/07/2011 | WO2011079817A1 Dendrimer of tuftsin and influenza matrix protein，and use thereof |
| 07/07/2011 | WO2011079627A1 Multi-component adjuvant of immersion vaccine for fish, and its application and using method |
| 07/07/2011 | WO2011079361A1 Modified bacterial strain and use thereof |
| 07/07/2011 | WO2011060246A3 A method of promoting dendritic spine density |
| 07/07/2011 | WO2011051726A3 Treatment of obesity |
| 07/07/2011 | WO2011045080A3 Monoclonal antibodies to progastrin and their uses |
| 07/07/2011 | WO2011032161A8 Vaccines directed to langerhans cells |
| 07/07/2011 | WO2011010098A3 Methods |
| 07/07/2011 | WO2011008092A4 Gram-positive bacteria specific binding compounds |
| 07/07/2011 | WO2011007359A3 Antigen specific multi epitope -based anti-infective vaccines |
| 07/07/2011 | WO2010077854A8 High affinity human antibodies to pcsk9 |
| 07/07/2011 | US20110167505 GFATS As Modifiers of the AXIN Pathway and Methods of Use |
| 07/07/2011 | US20110165668 MHC Class I Peptide Epitopes from the Human 5T4 Tumor-Associated Antigen |
| 07/07/2011 | US20110165659 Biological products |
| 07/07/2011 | US20110165627 Gene site saturation mutagenesis |
| 07/07/2011 | US20110165599 Monoclonal antibody therapy for pancreas cancer |
| 07/07/2011 | US20110165260 Allantoin-containing skin cream |
| 07/07/2011 | US20110165255 Malignant tumor heat therapy kit comprising anti-regulatory t cell antibody and magnetic fine particles and heat therapy method thereof |
| 07/07/2011 | US20110165250 Compositions and methods for treatment of neoplastic disease |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165227 Compositions and Methods Using siRNA Molecules for Treatment of Gliomas |
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165223 Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165196 Method for treatment of crib biting in animals |
| 07/07/2011 | US20110165194 HBV Vaccine and a Process of Preparing the Same |
| 07/07/2011 | US20110165193 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165192 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165191 Tat dna sequences, gene constructs, vaccine and processes thereof |
| 07/07/2011 | US20110165190 Compositions and Methods for Immunizing Against Immunodeficiency Viruses |
| 07/07/2011 | US20110165189 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/07/2011 | US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/07/2011 | US20110165187 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 07/07/2011 | US20110165185 Immunogenic peptides |
| 07/07/2011 | US20110165184 Cdh3 peptide and medicinal agent comprising the same |
| 07/07/2011 | US20110165183 Piperidine derivatives as jak3 inhibitors |
| 07/07/2011 | US20110165182 Conjugate of an antibody against ccr5 and an antifusogenic peptide |
| 07/07/2011 | US20110165181 Relay vaccine |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/07/2011 | US20110165179 Therapeutic agents for alzheimer's disease and cancer |
| 07/07/2011 | US20110165178 Diagnosis of prostate cancer |
| 07/07/2011 | US20110165177 Methods of Modulating Immunity |
| 07/07/2011 | US20110165176 Aldosterone induced vascular elastin production |
| 07/07/2011 | US20110165175 Antibody of human origin for inhibiting thrombocytes aggregation |
| 07/07/2011 | US20110165174 Alternatively Transcribed Genes Associated with Memory Consolidation |
| 07/07/2011 | US20110165173 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for salusin |
| 07/07/2011 | US20110165172 Method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection |
| 07/07/2011 | US20110165171 Antibodies that bind par-2 |
| 07/07/2011 | US20110165170 Osteopontin antibodies |
| 07/07/2011 | US20110165169 Complement inhibitors and uses thereof |
| 07/07/2011 | US20110165168 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 07/07/2011 | US20110165167 Noval madcam antibodies |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |
| 07/07/2011 | US20110165164 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 07/07/2011 | US20110165163 Identification of a conserved inner core oligosaccharide of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 07/07/2011 | US20110165162 Methods for Treating Cancers Comprising K-ras Mutations |
| 07/07/2011 | US20110165161 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same |
| 07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
| 07/07/2011 | US20110165159 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant |
| 07/07/2011 | US20110165158 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist |
| 07/07/2011 | US20110165157 Extending time to disease progression or survival in cancer patients |
| 07/07/2011 | US20110165156 Antibodies against human csf-1r and uses thereof |
| 07/07/2011 | US20110165155 Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1 |
| 07/07/2011 | US20110165154 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 07/07/2011 | US20110165153 Anti cd37 antibodies |
| 07/07/2011 | US20110165152 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 07/07/2011 | US20110165151 Combination therapy of an afucosylated cd20 antibody with bendamustine |
| 07/07/2011 | US20110165150 Isolated organ perfusion combination therapy of cancer |
| 07/07/2011 | US20110165149 Targeting abcb5 for cancer therapy |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 07/07/2011 | US20110165146 Methods of diagnosing alzheimer's disease |
| 07/07/2011 | US20110165145 Igf-ii/igf-iie binding proteins |
| 07/07/2011 | US20110165144 Methods for treating rheumatoid arthritis |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165122 Method for targeted and sustained antiviral therapy |